Get started
Author

Md Masud Un Nabi

Observed name: MD. Masud Un Nabi
ORCID: 0000-0002-8749-2575
Observed ORCID: 0000-0002-8749-2575
OpenAlex ID: A5047976273
Prevalence and patterns of dyslipidemia among lipid-lowering drug-naïve patients with type 2 diabetes mellitus – A countrywide study in Bangladesh
2023 · A.B.M. Kamrul-Hasan, Muhammad Shah Alam, et al. · Endocrine and Metabolic Science · 12
Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study
2023 · Shahjada Selim, Muhammad Shah Alam, et al. · BMC Endocrine Disorders · 9
PDF
Comparison of fasting and random lipid profiles among subjects with type 2 diabetes mellitus: an outpatient-based cross-sectional study in Bangladesh
2023 · A. B. M. Kamrul-Hasan, Samir Kumar Talukder, et al. · Diabetology & Metabolic Syndrome · 6
PDF
Clinical and biochemical outcome of patients with polycystic ovary syndrome managed with life style modification or combination with metformin
2019 · Md Masud Un Nabi, Md Faruque Pathan, et al. · BIRDEM Medical Journal · 1
PDF
General characteristics, risk-stratified and sex-stratified clinical outcomes in Bangladeshi people with type 2 diabetes mellitus who fasted during Ramadan 2022: A multicenter, real-world, cross-sectional study
2026 · Md Fariduddin, Murshed Ahamed Khan, et al. · Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
PDF
Beyond glycemic control: The role of Tirzepatide in MASLD and OSA management
2025 · MD. Masud Un Nabi · Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
PDF
Bardet Biedl Syndrome: A Case Report
2019 · Md Masud Un Nabi, Md Faruque Pathan, et al. · BIRDEM Medical Journal
PDF
Works count: 7
Citation count: 28
H-index: 3
I10-index: 1
Year
Topic
Type